Raymond James & Associates’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.75M | Sell |
|
|||||
|
2024
Q2 | $3.31M | Buy |
|
|||||
|
2024
Q1 | $3.37M | Buy |
|
|||||
|
2023
Q4 | $3.17M | Buy |
|
|||||
|
2023
Q3 | $2.56M | Sell |
|
|||||
|
2023
Q2 | $2.7M | Buy |
|
|||||
|
2023
Q1 | $2.35M | Buy |
|
|||||
|
2022
Q4 | $1.99M | Buy |
|
|||||
|
2022
Q3 | $1.33M | Sell |
|
|||||
|
2022
Q2 | $1.58M | Sell |
|
|||||
|
2022
Q1 | $1.89M | Buy |
|
|||||
|
2021
Q4 | $1.41M | Sell |
|
|||||
|
2021
Q3 | $3.69M | Sell |
|
|||||
|
2021
Q2 | $4.09M | Buy |
|
|||||
|
2021
Q1 | $4.14M | Sell |
|
|||||
|
2020
Q4 | $18.4M | Sell |
|
|||||
|
2020
Q3 | $19.5M | Sell |
|
|||||
|
2020
Q2 | $20.9M | Sell |
|
|||||
|
2020
Q1 | $18.4M | Buy |
|
|||||
|
2019
Q4 | $20.5M | Buy |
|
|||||
|
2019
Q3 | $16.4M | Buy |
|
|||||
|
2019
Q2 | $12.2M | Buy |
|
|||||
|
2019
Q1 | $10.2M | Buy |
|
|||||
|
2018
Q4 | $727K | Buy |
|